跳至主要内容
临床试验/CTRI/2023/08/056980
CTRI/2023/08/056980尚未招募4 期

Evaluation of efficacy and safety of vitamin D3 as an add on therapy to diclofenac for treatment of mastalgia: A randomised controlled trial

BPSGMC KHANPUR KALAN, SONEPAT0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who are willing to give written informed consent to participate in the study.
  • 2. Treatment naïve female patients of age group 15-45 years presenting with
  • mastalgia = 5 days in the prior month and pain intensity = 3 on VAS scale.

排除标准

  • 1. Patient with known or suspected breast cancer.
  • 2. Scoring more than 3 on BIRADS classification on ultrasonography [Annexure-3]
  • 3. Patient with infective or inflammatory mastitis.
  • 4. Patient with severe deficiency of vitamin D ( < 10 ng/ml)
  • 5. Recent history of therapeutic vitamin D3 consumption.
  • 6. Women on oral contraceptives and other hormonal therapies.
  • 7. Patients who have a history of hypersensitivity to any of the
  • study drugs or any contraindication to any drug involved in this study.
  • 8. Patients with an education level less than 5th standard.

研究者

发起方
BPSGMC KHANPUR KALAN, SONEPAT

相似试验